Action Harbor Health Care ETF

Outils de qualité professionnelle, pour des investisseurs individuels.

Premium

Dernier

26,3902

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

24,40 Plage de 52 semaines 28,40

Clôture Veille

26,3902

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

2 152

Volume financier

VWAP

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

GAITHERSBURG, Md., June 18 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that, in connection with the closing of the acquisition of MedImmune by AstraZeneca PLC pursuant to a...

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

Biotechnology Company Honored for Internal Launch of Productivity Tracking System GAITHERSBURG, Md., June 12 /PRNewswire-FirstCall/ -- MedImmune, Inc. today announced that the company was...

MedImmune Named One of Maryland's Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

- 10th Consecutive Year for MedImmune on the Fast 50 List - GAITHERSBURG, Md., Sept. 29 /PRNewswire-FirstCall/ -- MedImmune, Inc. has been named to Deloitte's Maryland Technology Fast 50 program...

MedImmune Named One Of Maryland's Fastest Growing Technology Companies In Deloitte Technology Fast 50 Program

GAITHERSBURG, Md., Oct. 12 /PRNewswire-FirstCall/ -- MedImmune, Inc. has been named to Deloitte's Maryland Technology Fast 50 program for the ninth consecutive year. The Technology Fast 50 is a...

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices NEW YORK, Dec. 10 /PRNewswire/ -- Standard & Poor's will make its semi-annual changes...

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- Data presented today from a Phase 3...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0.7243	2.82203234642	25.6659	26.45	25.58	1246	26.13802558	SP
4	1.5902	6.41209677419	24.8	26.45	24.66	3200	25.31918798	SP
12	-0.3398	-1.27123082679	26.73	27.07	24.66	2152	25.74780721	SP
26	-0.6698	-2.47524020695	27.06	28.4	24.66	1694	26.41042797	SP
52	1.4102	5.645316253	24.98	28.4	24.4	2913	26.41148923	SP
156	6.6902	33.9604060914	19.7	28.4	19.6174	1898	25.33522457	SP
260	6.6902	33.9604060914	19.7	28.4	19.6174	1898	25.33522457	SP

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Harbor Health Care ETF (MEDI)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

MEDI Dernières nouvelles

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

MedImmune Named One of Maryland's Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

MedImmune Named One Of Maryland's Fastest Growing Technology Companies In Deloitte Technology Fast 50 Program

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Harbor Health Care ETF (MEDI) Cours

Harbor Health Care ETF (MEDI)

Outils de qualité professionnelle, pour des investisseurs individuels.

Statistiques et détails clés

MEDI Dernières nouvelles

MedImmune, Inc. Announces Make-Whole Fundamental Change Relating to its 1.375% Convertible Senior Notes Due 2011 and 1.625% Conv

MedImmune Wins Stevie(R) Award at 5th Annual American Business Awards(SM)

MedImmune Named One of Maryland's Fastest Growing Technology Companies in Deloitte Technology Fast 50 Program

MedImmune Named One Of Maryland's Fastest Growing Technology Companies In Deloitte Technology Fast 50 Program

Standard & Poor's Announces Semi-Annual Reconstitution of Standard & Poor's/Barra Growth and Value Indices

Data Show Ethyol(R) Reduces Radiation Therapy-Induced Dry Mouth in Head and Neck Cancer Patients For 24 Months

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application